These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14998780)

  • 1. Genetically recombinant antibodies: new therapeutics against candidiasis.
    Burnie J; Matthews R
    Expert Opin Biol Ther; 2004 Feb; 4(2):233-41. PubMed ID: 14998780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human recombinant antibody to HSP90: a natural partner in combination therapy.
    Matthews RC; Burnie JP
    Curr Mol Med; 2005 Jun; 5(4):403-11. PubMed ID: 15977996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.
    Matthews RC; Rigg G; Hodgetts S; Carter T; Chapman C; Gregory C; Illidge C; Burnie J
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2208-16. PubMed ID: 12821470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal antibodies: a new approach to the treatment of systemic candidiasis.
    Matthews R; Burnie J
    Curr Opin Investig Drugs; 2001 Apr; 2(4):472-6. PubMed ID: 11566001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.
    Pachl J; Svoboda P; Jacobs F; Vandewoude K; van der Hoven B; Spronk P; Masterson G; Malbrain M; Aoun M; Garbino J; Takala J; Drgona L; Burnie J; Matthews R;
    Clin Infect Dis; 2006 May; 42(10):1404-13. PubMed ID: 16619152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant antibodies: a natural partner in combinatorial antifungal therapy.
    Matthews RC; Burnie JP
    Vaccine; 2004 Feb; 22(7):865-71. PubMed ID: 15040939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of anti-Candida antibodies in immunoprophylaxis.
    Cabezas J; Albaina O; Montañez D; Sevilla MJ; Moragues MD; Pontón J
    Immunotherapy; 2010 Mar; 2(2):171-83. PubMed ID: 20635926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies.
    Nooney L; Matthews RC; Burnie JP
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):19-29. PubMed ID: 15629225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against Candida: potential therapeutics?
    Matthews R; Burnie J
    Trends Microbiol; 1996 Sep; 4(9):354-8. PubMed ID: 8885170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody-based therapy in the treatment of invasive candidiasis.
    Bugli F; Cacaci M; Martini C; Torelli R; Posteraro B; Sanguinetti M; Paroni Sterbini F
    Clin Dev Immunol; 2013; 2013():403121. PubMed ID: 23878583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole.
    Sutherland A; Ellis D
    Pediatr Crit Care Med; 2008 Jul; 9(4):e23-5. PubMed ID: 18843247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of hybrid phage displaying antigen epitope and recombinant protein in the diagnosis of systemic Candida albicans infection in rabbits and cancer patients.
    Quanping S; Yanyan H; Yicun W; Zhigang J; Yuling G; Li W
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):382-9. PubMed ID: 20884151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
    Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
    Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis.
    Matthews R; Hodgetts S; Burnie J
    J Infect Dis; 1995 Jun; 171(6):1668-71. PubMed ID: 7539475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efungumab: a novel agent in the treatment of invasive candidiasis.
    Karwa R; Wargo KA
    Ann Pharmacother; 2009 Nov; 43(11):1818-23. PubMed ID: 19773528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1.
    Laín A; Elguezabal N; Brena S; García-Ruiz JC; Del Palacio A; Moragues MD; Pontón J
    BMC Microbiol; 2007 Apr; 7():35. PubMed ID: 17448251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hsp90 in fungal infection.
    Matthews R; Burnie J
    Immunol Today; 1992 Sep; 13(9):345-8. PubMed ID: 1466751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the usefulness of anti-glyceraldehyde-3-phosphate dehydrogenase antibodies as a treatment for invasive candidiasis in a murine model.
    Gil ML; Dagan S; Eren R; Gozalbo D
    Antonie Van Leeuwenhoek; 2006; 89(3-4):345-50. PubMed ID: 16779630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycograb for the treatment of invasive candidiasis.
    Herbrecht R; Fohrer C; Nivoix Y
    Clin Infect Dis; 2006 Oct; 43(8):1083; author reply 1083-4. PubMed ID: 16983626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.